Elekta AB (publ) (OTCMKTS:EKTAY) Sees Significant Growth in Short Interest

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 400 shares, an increase of 300.0% from the February 28th total of 100 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 22,500 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

Elekta AB (publ) Price Performance

Shares of OTCMKTS EKTAY traded down $0.16 during mid-day trading on Thursday, reaching $5.36. 3,313 shares of the company were exchanged, compared to its average volume of 9,255. Elekta AB has a 52 week low of $5.25 and a 52 week high of $8.24. The company’s 50 day moving average price is $5.76 and its 200 day moving average price is $5.94. The stock has a market capitalization of $2.05 billion, a PE ratio of 21.42 and a beta of 1.25. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60.

Elekta AB (publ) (OTCMKTS:EKTAY) last announced its quarterly earnings data on Friday, February 21st. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. The business had revenue of $416.86 million during the quarter, compared to the consensus estimate of $435.89 million. Sell-side analysts forecast that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, March 27th. Shareholders of record on Friday, March 7th will be given a dividend of $0.1072 per share. The ex-dividend date is Friday, March 7th. Elekta AB (publ)’s payout ratio is 44.00%.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.